Figure 3.

Expression of phosphorylated platelet-derived growth factor receptor in the papillary dermis following rituximab administration. Rituximab (RTX) mediates a significant attenuation in platelet-derived growth factor receptor (PDGFR) phosphorylation (activation) status. (A) Phospho-PDGFRα and (B) phospho-PDGFRβ expression is decreased following RTX administration.

Daoussis et al. Arthritis Research & Therapy 2012 14:R145   doi:10.1186/ar3879
Download authors' original image